Titan Pharmaceuticals Statistics
Total Valuation
TTNP has a market cap or net worth of $4.25 million. The enterprise value is $2.31 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TTNP has 914,234 shares outstanding. The number of shares has increased by 17.59% in one year.
| Current Share Class | 914,234 |
| Shares Outstanding | 914,234 |
| Shares Change (YoY) | +17.59% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 66.36% |
| Owned by Institutions (%) | 2.92% |
| Float | 307,522 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.27 |
| P/TBV Ratio | 2.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.73
| Current Ratio | 7.73 |
| Quick Ratio | 7.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -105.70% and return on invested capital (ROIC) is -62.96%.
| Return on Equity (ROE) | -105.70% |
| Return on Assets (ROA) | -57.20% |
| Return on Invested Capital (ROIC) | -62.96% |
| Return on Capital Employed (ROCE) | -214.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.05M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.94% in the last 52 weeks. The beta is 1.31, so TTNP's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -29.94% |
| 50-Day Moving Average | 4.16 |
| 200-Day Moving Average | 4.24 |
| Relative Strength Index (RSI) | 53.36 |
| Average Volume (20 Days) | 81,030 |
Short Selling Information
The latest short interest is 8,292, so 0.91% of the outstanding shares have been sold short.
| Short Interest | 8,292 |
| Short Previous Month | 8,680 |
| Short % of Shares Out | 0.91% |
| Short % of Float | 2.70% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.03M |
| Pretax Income | -4.95M |
| Net Income | -4.21M |
| EBITDA | -4.02M |
| EBIT | -4.03M |
| Earnings Per Share (EPS) | -$4.60 |
Full Income StatementBalance Sheet
The company has $1.95 million in cash and n/a in debt, giving a net cash position of $1.95 million or $2.13 per share.
| Cash & Cash Equivalents | 1.95M |
| Total Debt | n/a |
| Net Cash | 1.95M |
| Net Cash Per Share | $2.13 |
| Equity (Book Value) | 1.88M |
| Book Value Per Share | 2.05 |
| Working Capital | 1.88M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.13M |
| FCF Per Share | -$4.52 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |